Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer.

Smeby J, Sveen A, Bergsland CH, Eilertsen IA, Danielsen SA, Eide PW, Hektoen M, Guren MG, Nesbakken A, Bruun J, Lothe RA.

ESMO Open. 2019 Jun 24;4(3):e000523. doi: 10.1136/esmoopen-2019-000523. eCollection 2019.

2.

Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer.

Smeby J, Sveen A, Eilertsen IA, Danielsen SA, Hoff AM, Eide PW, Johannessen B, Hektoen M, Skotheim RI, Guren MG, Nesbakken A, Lothe RA.

Oncogenesis. 2019 May 15;8(6):35. doi: 10.1038/s41389-019-0141-3.

3.

Long noncoding RNA MIR31HG is a bona fide prognostic marker with colorectal cancer cell-intrinsic properties.

Eide PW, Eilertsen IA, Sveen A, Lothe RA.

Int J Cancer. 2019 Jun 1;144(11):2843-2853. doi: 10.1002/ijc.31998. Epub 2019 Jan 12.

4.

Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer.

Bruun J, Sveen A, Barros R, Eide PW, Eilertsen I, Kolberg M, Pellinen T, David L, Svindland A, Kallioniemi O, Guren MG, Nesbakken A, Almeida R, Lothe RA.

Mol Oncol. 2018 Sep;12(9):1639-1655. doi: 10.1002/1878-0261.12347. Epub 2018 Aug 15.

5.

Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies.

Sveen A, Bruun J, Eide PW, Eilertsen IA, Ramirez L, Murumägi A, Arjama M, Danielsen SA, Kryeziu K, Elez E, Tabernero J, Guinney J, Palmer HG, Nesbakken A, Kallioniemi O, Dienstmann R, Lothe RA.

Clin Cancer Res. 2018 Feb 15;24(4):794-806. doi: 10.1158/1078-0432.CCR-17-1234. Epub 2017 Dec 14.

6.

CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models.

Eide PW, Bruun J, Lothe RA, Sveen A.

Sci Rep. 2017 Nov 30;7(1):16618. doi: 10.1038/s41598-017-16747-x.

7.

The E3 ubiquitin ligase NEDD4 induces endocytosis and lysosomal sorting of connexin 43 to promote loss of gap junctions.

Totland MZ, Bergsland CH, Fykerud TA, Knudsen LM, Rasmussen NL, Eide PW, Yohannes Z, Sørensen V, Brech A, Lothe RA, Leithe E.

J Cell Sci. 2017 Sep 1;130(17):2867-2882. doi: 10.1242/jcs.202408. Epub 2017 Jul 21.

8.

Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies.

Berg KCG, Eide PW, Eilertsen IA, Johannessen B, Bruun J, Danielsen SA, Bjørnslett M, Meza-Zepeda LA, Eknæs M, Lind GE, Myklebost O, Skotheim RI, Sveen A, Lothe RA.

Mol Cancer. 2017 Jul 6;16(1):116. doi: 10.1186/s12943-017-0691-y.

9.

MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer.

Cekaite L, Eide PW, Lind GE, Skotheim RI, Lothe RA.

Oncotarget. 2016 Feb 9;7(6):6476-505. doi: 10.18632/oncotarget.6390. Review.

10.

Portrait of the PI3K/AKT pathway in colorectal cancer.

Danielsen SA, Eide PW, Nesbakken A, Guren T, Leithe E, Lothe RA.

Biochim Biophys Acta. 2015 Jan;1855(1):104-21. doi: 10.1016/j.bbcan.2014.09.008. Epub 2014 Nov 22. Review.

PMID:
25450577
11.

Epigenetic and genetic features of 24 colon cancer cell lines.

Ahmed D, Eide PW, Eilertsen IA, Danielsen SA, Eknæs M, Hektoen M, Lind GE, Lothe RA.

Oncogenesis. 2013 Sep 16;2:e71. doi: 10.1038/oncsis.2013.35.

12.

NEDD4 is overexpressed in colorectal cancer and promotes colonic cell growth independently of the PI3K/PTEN/AKT pathway.

Eide PW, Cekaite L, Danielsen SA, Eilertsen IA, Kjenseth A, Fykerud TA, Ågesen TH, Bruun J, Rivedal E, Lothe RA, Leithe E.

Cell Signal. 2013 Jan;25(1):12-8. doi: 10.1016/j.cellsig.2012.08.012. Epub 2012 Sep 5.

PMID:
22974840

Supplemental Content

Support Center